HIV Therapeutics Market estimated to grow at a CAGR of 1.4 % by 2021 May.2017 | Page 2
Global HIV Therapeutics Market
According to the report “HIV Therapeutic Market”, published by Market Data Forecast, the
global market is projected to reach USD 14.2 Billion by 2021, at a CAGR of 1.4% from 2016
to 2021.
The human immunodeficiency infection (HIV) refers to a kind of retrovirus that causes (AIDS).
HIV assaults some immune cells and it weakens immune system bringing about loss of
capacity to fight against the organisms that causes diseases. HIV contamination has no cure
however there are medicines which help to balance out or decrease this infection so it doesn't
prompt to AIDS. HIV therapeutics market is developing at a significant rate because of
increment in the HIV contaminated cases and developing awareness about the same. HIV
disease can be treated with different therapeutics.
Increasing number of HIV affected cases, innovative advancement in HIV diagnosis and
therapeutics, ascend in research exercises for developing HIV immunizations and not aware
about the methods of transmission of the infection are driving the worldwide market for HIV
therapeutics. Different variables, for example, disappointment of treatment sometimes,
absence of gifted experts and presentation of non-specific medications in the market are
major restraints the HIV therapeutics market.
Market segmented by Type
Nucleoside/tide reverse transcriptase inhibitors
nucleoside/tide analogues
Non-nucleoside reverse transcriptase inhibitors
Protease inhibitors
Integrase [strand transfer] inhibitors
CCR5 inhibitors, Fusion inhibitors)
Market segmented by Medical Application
HIV Type-1
HIV Type-2
Geographical Segmentation
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Major players involved in managing in HIV therapeutics are GlaxoSmithKline, Bristol-Myers
Squibb, Pfizer and Boehringer Ingelheim. Other organizations having huge presence in HIV
therapeutics market are Merck, Hoffmann-La Roche and Gilead Sciences.
TABLE OF CONTENTS
+1-888-702-9626 | www.marketdataforecast.com | [email protected]